| Profiles RNS

Profile

ScD, Harvard School of Public Health
MPH, University of Massachusetts Amherst
BS, University of Wisconsin Madison

Pronouns: she/her/hers

Websites

	Twitter
	Mendeley Profile
	School of Public Health Faculty
	ORCID
	My NCBI
	Google Scholar

ORCID : 0000-0002-2637-6036

BU Research
Other Research

Racial Differences in Splice Variants in Men with Localized Prostate Cancer
03/01/2018 - 01/30/2020 (PI)
Massachusetts General Hospital

Title

Patterns in long-term prescription opioid use in patients with cancer who are HIV-infected and HIV-uninfected
02/01/2019 - 01/31/2020 (PI)
BU/BMC

ACS Institutional Research Grant Pilot Award
02/01/2019 - 01/31/2020 (PI)
BU/BMC

Novel Method for Surrogate Endpoint Evaluation in Prostate Cancer Trials
10/05/2018 - 10/31/2019 (Co-PI)
PI: Jennifer R. Rider, ScD, MPH
BU SPH

Novel Method for Surrogate Endpoint Evaluation in Prostate Cancer Trials
10/05/2018 - 10/31/2019 (Co-PI)
PI: Jennifer R. Rider, ScD, MPH
Boston University School of Public Health

Gene expression profiles in prostate tumors according to HIV status
05/01/2016 - 04/30/2017 (PI)
Boston University School of Public Health

Gene expression profiles in prostate tumors according to HIV status
05/01/2016 - 04/30/2017 (PI)
BU SPH

The Immunomodulatory and Androgen-Associated Actions of Vitamin D in Prostate Cancer
05/20/2013 - 05/20/2016 (PI)
Prostate Cancer Foundation

The Immunomodulatory and Androgen-Associated Actions of Vitamin D in Prostate Cancer
05/20/2013 - 05/20/2016 (PI)
Prostate Cancer Foundation

Chronic Stress and Racial Disparities in Prostate Cancer
09/01/2013 - 08/31/2015 (PI)
Dana Farber/Harvard Cancer Center

Inflammation and Tissue Microenvironment as Predictors of Prostate Cancer Risk, Mortality and Therapy Response among Men with an Initially Benign TURP
08/01/2012 - 07/31/2014 (PI)
Dana Farber/Harvard Cancer Cente

Showing 10 of 11 results. Show All Results

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Borno HT, Rider JR, Gunn CM. The Ethics of Delivering Precision Medicine-Pretest Counseling and Somatic Genomic Testing. JAMA Oncol. 2020 06 01; 6(6):815-816.View Related Profiles.

Gunn, Christine
Rider, Jennifer

PMID: 32163096; PMCID: PMC7814415; DOI: 10.1001/jamaoncol.2020.0016;

Connors K, Flores-Torres MH, Stern D, Valdimarsdóttir U, Rider JR, Lopez-Ridaura R, Kirschbaum C, Cantú-Brito C, Catzin-Kuhlmann A, Rodriguez BL, Correa CP, Lajous M. Family Member Incarceration, Psychological Stress, and Subclinical Cardiovascular Disease in Mexican Women (2012-2016). Am J Public Health. 2020 01; 110(S1):S71-S77. PMID: 31967877

Bernard B, Burnett C, Sweeney CJ, Rider JR, Sridhar SS. Impact of age at diagnosis of de novo metastatic prostate cancer on survival. Cancer. 2020 03 01; 126(5):986-993. PMID: 31769876

Allott EH, Ebot EM, Stopsack KH, Gonzalez-Feliciano AG, Markt SC, Wilson KM, Ahearn TU, Gerke TA, Downer MK, Rider JR, Freedland SJ, Lotan TL, Kantoff PW, Platz EA, Loda M, Stampfer MJ, Giovannucci E, Sweeney CJ, Finn SP, Mucci LA. Statin Use Is Associated with Lower Risk of PTEN-Null and Lethal Prostate Cancer. Clin Cancer Res. 2020 03 01; 26(5):1086-1093. PMID: 31754047

Rider JR, Trinquart L. Observational Studies Have a Critical Role to Play in Cancer Comparative Effectiveness Research. J Clin Oncol. 2019 10 10; 37(29):2695-2696.View Related Profiles.

Rider, Jennifer
Trinquart, Ludovic

PMID: 31465256

Lajous M, Cooperberg MR, Rider J, Manzanilla-García HA, Gabilondo-Navarro FB, Rodríguez-Covarrubias FT, López-Ridaura R, Torres-Sánchez LE, Mohar A. Prostate cancer screening in low- and middle-income countries: the Mexican case. Salud Publica Mex. 2019 Jul-Aug; 61(4):542-544. PMID: 31314214; DOI: 10.21149/10373;

Kantor ED, Haneuse S, Valdimarsdóttir UA, Williams DR, Signorello LB, Rider JR. Socioenvironmental adversity and risk of prostate cancer in non-Hispanic black and white men. Cancer Causes Control. 2019 Sep; 30(9):997-1007. PMID: 31264140

Trinquart L, Bill-Axelson A, Rider JR. Restricted Mean Survival Times to Improve Communication of Evidence from Cancer Randomized Trials and Observational Studies. Eur Urol. 2019 Aug; 76(2):137-139.View Related Profiles.

Rider, Jennifer
Trinquart, Ludovic

PMID: 31031048

Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou CK, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, Sesso HD, Finn S, Giovannucci EL, Gleave M, Loda M, Li Z, Pollak M, Mucci LA. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis. 2018 12 31; 39(12):1431-1437. PMID: 30165429

Vicier C, Werner L, Chipman J, Harshman LC, Patil DH, Fichorova RN, Rider JR, Sanda MG, Mucci LA, Sweeney CJ. Elevated Serum Cytokines and Trichomonas vaginalis Serology at Diagnosis Are Not Associated With Higher Gleason Grade or Lethal Prostate Cancer. Clin Genitourin Cancer. 2019 Feb; 17(1):32-37. PMID: 30348512

Showing 10 of 99 results. Show More

Johnson-Obaseki S, Caulley L, Corsten M, Liu G, Dimitroulakos J, Goldstein D, Irish J, Rider J. C-reactive Protein in HPV-Positive and HPV-Negative Oropharyngeal Cancer. Otolaryngol Head Neck Surg. 2019 03; 160(3):494-501. PMID: 30226795

Davidsson S, Carlsson J, Giunchi F, Harlow A, Kirrander P, Rider J, Fiorentino M, Andrén O. PD-L1 Expression in Men with Penile Cancer and its Association with Clinical Outcomes. Eur Urol Oncol. 2019 03; 2(2):214-221. PMID: 31017099

DuPre NC, Flavin R, Sfanos KS, Unger RH, To S, Gazeeva E, Fiorentino M, De Marzo AM, Rider JR, Mucci LA. Corpora amylacea in prostatectomy tissue and associations with molecular, histological, and lifestyle factors. Prostate. 2018 11; 78(15):1172-1180. PMID: 30009541

Stopsack KH, Ebot EM, Downer MK, Gerke TA, Rider JR, Kantoff PW, Mucci LA. Regular aspirin use and gene expression profiles in prostate cancer patients. Cancer Causes Control. 2018 Aug; 29(8):775-784. PMID: 29915914

Sinnott JA, Brumberg K, Wilson KM, Ebot EM, Giovannucci EL, Mucci LA, Rider JR. Differential Gene Expression in Prostate Tissue According to Ejaculation Frequency. Eur Urol. 2018 11; 74(5):545-548. PMID: 29784192

Erlandsson A, Carlsson J, Andersson SO, Vyas C, Wikström P, Andrén O, Davidsson S, Rider JR. High inducible nitric oxide synthase in prostate tumor epithelium is associated with lethal prostate cancer. Scand J Urol. 2018 Apr; 52(2):129-133. PMID: 29307261; DOI: 10.1080/21681805.2017.1421261;

Börnigen D, Ren B, Pickard R, Li J, Ozer E, Hartmann EM, Xiao W, Tickle T, Rider J, Gevers D, Franzosa EA, Davey ME, Gillison ML, Huttenhower C. Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer. Sci Rep. 2017 12 15; 7(1):17686. PMID: 29247187

Davidsson S, Andren O, Ohlson AL, Carlsson J, Andersson SO, Giunchi F, Rider JR, Fiorentino M. FOXP3+ regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer. Prostate. 2018 Jan; 78(1):40-47. PMID: 29105795

Stopsack KH, Gerke TA, Andrén O, Andersson SO, Giovannucci EL, Mucci LA, Rider JR. Cholesterol uptake and regulation in high-grade and lethal prostate cancers. Carcinogenesis. 2017 08 01; 38(8):806-811. PMID: 28595267

Ebot EM, Gerke T, Labbé DP, Sinnott JA, Zadra G, Rider JR, Tyekucheva S, Wilson KM, Kelly RS, Shui IM, Loda M, Kantoff PW, Finn S, Vander Heiden MG, Brown M, Giovannucci EL, Mucci LA. Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer. Cancer. 2017 Nov 01; 123(21):4130-4138. PMID: 28700821

Pernar CH, Fall K, Rider JR, Markt SC, Adami HO, Andersson SO, Valdimarsdottir U, Andrén O, Mucci LA. A Walking Intervention Among Men With Prostate Cancer: A Pilot Study. Clin Genitourin Cancer. 2017 Dec; 15(6):e1021-e1028. PMID: 28668276

Giunchi F, Jordahl K, Bollito E, Colecchia M, Patriarca C, D'Errico A, Vasuri F, Malvi D, Fornari A, Bonetti LR, Corti B, Papotti M, DeGiuli P, Loda M, Montironi R, Fiorentino M, Rider JR. Interpathologist concordance in the histological diagnosis of focal prostatic atrophy lesions, acute and chronic prostatitis, PIN, and prostate cancer. Virchows Arch. 2017 Jun; 470(6):711-715. PMID: 28405833; DOI: 10.1007/s00428-017-2123-1;

Rider JR. Invited commentary re: Nair-Shalliker V et al., Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: Results from the New Wales Lifestyle and Evaluation of Risk Study (CLEAR). Practice Update: Urology. 2017. View Publication

Pettersson A, Gerke T, Fall K, Pawitan Y, Holmberg L, Giovannucci EL, Kantoff PW, Adami HO, Rider JR, Mucci LA. The ABC model of prostate cancer: A conceptual framework for the design and interpretation of prognostic studies. Cancer. 2017 May 01; 123(9):1490-1496. PMID: 28152172; DOI: 10.1002/cncr.30582;

Zareba P, Flavin R, Isikbay M, Rider JR, Gerke TA, Finn S, Pettersson A, Giunchi F, Unger RH, Tinianow AM, Andersson SO, Andrén O, Fall K, Fiorentino M, Mucci LA. Perineural Invasion and Risk of Lethal Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2017 May; 26(5):719-726. PMID: 28062398; DOI: 10.1158/1055-9965.EPI-16-0237;

Wilson KM, Markt SC, Fang F, Nordenvall C, Rider JR, Ye W, Adami HO, Stattin P, Nyrén O, Mucci LA. Snus use, smoking and survival among prostate cancer patients. Int J Cancer. 2016 Dec 15; 139(12):2753-2759. PMID: 27582277; DOI: 10.1002/ijc.30411;

Markt SC, Nuttall E, Turman C, Sinnott J, Rimm EB, Ecsedy E, Unger RH, Fall K, Finn S, Jensen MK, Rider JR, Kraft P, Mucci LA. Sniffing out significant "Pee values": genome wide association study of asparagus anosmia. BMJ. 2016 Dec 13; 355:i6071. PMID: 27965198; DOI: 10.1136/bmj.i6071;

Kelly RS, Sinnott JA, Rider JR, Ebot EM, Gerke T, Bowden M, Pettersson A, Loda M, Sesso HD, Kantoff PW, Martin NE, Giovannucci EL, Tyekucheva S, Heiden MV, Mucci LA. The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study. Cancer Metab. 2016; 4:22. PMID: 27980733

Sinnott JA, Peisch SF, Tyekucheva S, Gerke T, Lis R, Rider JR, Fiorentino M, Stampfer MJ, Mucci LA, Loda M, Penney KL. Prognostic Utility of a New mRNA Expression Signature of Gleason Score. Clin Cancer Res. 2017 Jan 01; 23(1):81-87. PMID: 27663590; DOI: 10.1158/1078-0432.CCR-16-1245;

Sigurdardottir LG, Markt SC, Sigurdsson S, Aspelund T, Fall K, Schernhammer E, Rider JR, Launer L, Harris T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA. Pineal Gland Volume Assessed by MRI and Its Correlation with 6-Sulfatoxymelatonin Levels among Older Men. J Biol Rhythms. 2016 Oct; 31(5):461-9. PMID: 27449477; DOI: 10.1177/0748730416656948;

Yang M, Zu K, Mucci LA, Rider JR, Fiorentino M, Clinton SK, Loda M, Stampfer MJ, Giovannucci E. Vascular morphology differentiates prostate cancer mortality risk among men with higher Gleason grade. Cancer Causes Control. 2016 Aug; 27(8):1043-7. PMID: 27379990; PMCID: PMC4958547; DOI: 10.1007/s10552-016-0782-x;

Davidsson S, Mölling P, Rider JR, Unemo M, Karlsson MG, Carlsson J, Andersson SO, Elgh F, Söderquist B, Andrén O. Erratum to: Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer. Infect Agent Cancer. 2016; 11:36. PMID: 27335583; DOI: 10.1186/s13027-016-0084-7;

Stopsack KH, Gerke TA, Sinnott JA, Penney KL, Tyekucheva S, Sesso HD, Andersson SO, Andrén O, Cerhan JR, Giovannucci EL, Mucci LA, Rider JR. Cholesterol Metabolism and Prostate Cancer Lethality. Cancer Res. 2016 Aug 15; 76(16):4785-90. PMID: 27325648; PMCID: PMC4987257; DOI: 10.1158/0008-5472.CAN-16-0903;

Rider JR, Wilson KM, Mucci LA, Giovannucci EL. Reply to Cédric Annweiler, Pierre Bigot, and Spyridon N. Karras' Letter to the Editor re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer A. Sinnott, Rachel S. Kelly, Lorelei A. Muccia, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol 2016;70:974-82. Eur Urol. 2017 01; 71(1):e18. PMID: 27317088; DOI: 10.1016/j.eururo.2016.05.052;

Rider JR. Lead Time, Like Trains and Tides, Stops for No One. Eur Urol. 2017 02; 71(2):202-203. PMID: 27311361; DOI: 10.1016/j.eururo.2016.06.003;

Davidsson S, Mölling P, Rider JR, Unemo M, Karlsson MG, Carlsson J, Andersson SO, Elgh F, Söderquis B, Andrén O. Frequency and typing of Propionibacterium acnes in prostate tissue obtained from men with and without prostate cancer. Infect Agent Cancer. 2016; 11:26. PMID: 27284286; DOI: 10.1186/s13027-016-0074-9;

Rider JR, Wilson KM, Sinnott JA, Kelly RS, Mucci LA, Giovannucci EL. Reply to Herney Andrés García-Perdomo and Ramiro Manzano Nunez's Letter to the Editor Re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer M. Sinnott, Rachel S. Kelly, Lorelei A. Mucci, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol 2016;70:974-82: Looking Deeper: P-hacking and Some Other Bias. Eur Urol. 2016 12; 70(6):e156-e157. PMID: 27156131; DOI: 10.1016/j.eururo.2016.04.032;

Börnigen D, Tyekucheva S, Wang X, Rider JR, Lee GS, Mucci LA, Sweeney C, Huttenhower C. Computational Reconstruction of NF?B Pathway Interaction Mechanisms during Prostate Cancer. PLoS Comput Biol. 2016 Apr; 12(4):e1004820. PMID: 27078000; PMCID: PMC4831844; DOI: 10.1371/journal.pcbi.1004820;

Rider JR, Wilson KM, Sinnott JA, Kelly RS, Mucci LA, Giovannucci EL. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol. 2016 Dec; 70(6):974-982. PMID: 27033442; DOI: 10.1016/j.eururo.2016.03.027;

Shui IM, Kolb S, Hanson C, Sutcliffe S, Rider JR, Stanford JL. Trichomonas vaginalis infection and risk of advanced prostate cancer. Prostate. 2016 May; 76(7):620-3. PMID: 26818005; PMCID: PMC5002353; DOI: 10.1002/pros.23153;

Graff RE, Pettersson A, Lis RT, Ahearn TU, Markt SC, Wilson KM, Rider JR, Fiorentino M, Finn S, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Mucci LA. Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression. Am J Clin Nutr. 2016 Mar; 103(3):851-60. PMID: 26817504; PMCID: PMC4763492; DOI: 10.3945/ajcn.115.118703;

Thorgeirsson T, Jordahl KM, Flavin R, Epstein MM, Fiorentino M, Andersson SO, Andren O, Rider JR, Mosquera JM, Ingoldsby H, Fall K, Tryggvadottir L, Mucci LA. Intracellular location of BRCA2 protein expression and prostate cancer progression in the Swedish Watchful Waiting Cohort. Carcinogenesis. 2016 Mar; 37(3):262-8. PMID: 26775038; DOI: 10.1093/carcin/bgw001;

Markt SC, Flynn-Evans EE, Valdimarsdottir UA, Sigurdardottir LG, Tamimi RM, Batista JL, Haneuse S, Lockley SW, Stampfer M, Wilson KM, Czeisler CA, Rider JR, Mucci LA. Sleep Duration and Disruption and Prostate Cancer Risk: a 23-Year Prospective Study. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):302-8. PMID: 26677208; PMCID: PMC4767658; DOI: 10.1158/1055-9965.EPI-14-1274;

Ahearn TU, Pettersson A, Ebot EM, Gerke T, Graff RE, Morais CL, Hicks JL, Wilson KM, Rider JR, Sesso HD, Fiorentino M, Flavin R, Finn S, Giovannucci EL, Loda M, Stampfer MJ, De Marzo AM, Mucci LA, Lotan TL. A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer. J Natl Cancer Inst. 2016 Feb; 108(2). PMID: 26615022; PMCID: PMC4862436; DOI: 10.1093/jnci/djv346;

Montgomery S, Brus O, Hiyoshi A, Cao Y, Rider J, Fall K. Childhood exposures among mothers and Hodgkin's lymphoma in offspring. Cancer Epidemiol. 2015 Dec; 39(6):1006-9. PMID: 26590334; DOI: 10.1016/j.canep.2015.10.027;

Rider JR. Trouble in Paradise: Unmeasured Confounding in Registry-based Studies of Etiologic Factors. Eur Urol. 2016 05; 69(5):883-4. PMID: 26559127; DOI: 10.1016/j.eururo.2015.10.044;

Stopsack KH, Ziehr DR, Rider JR, Giovannucci EL. Metformin and prostate cancer mortality: a meta-analysis. Cancer Causes Control. 2016 Jan; 27(1):105-13. PMID: 26537119; DOI: 10.1007/s10552-015-0687-0;

Hurley PJ, Sundi D, Shinder B, Simons BW, Hughes RM, Miller RM, Benzon B, Faraj SF, Netto GJ, Vergara IA, Erho N, Davicioni E, Karnes RJ, Yan G, Ewing C, Isaacs SD, Berman DM, Rider JR, Jordahl KM, Mucci LA, Huang J, An SS, Park BH, Isaacs WB, Marchionni L, Ross AE, Schaeffer EM. Germline Variants in Asporin Vary by Race, Modulate the Tumor Microenvironment, and Are Differentially Associated with Metastatic Prostate Cancer. Clin Cancer Res. 2016 Jan 15; 22(2):448-58. PMID: 26446945; PMCID: PMC4715968; DOI: 10.1158/1078-0432.CCR-15-0256;

Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR, Suneja G, Kayembe MK, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S. Correction: Cancer Incidence following Expansion of HIV Treatment in Botswana. PLoS One. 2015; 10(9):e0138742.View Related Profiles.

Seage, George
Rider, Jennifer

PMID: 26376079; DOI: 10.1371/journal.pone.0138742;

Dryden-Peterson S, Medhin H, Kebabonye-Pusoentsi M, Seage GR, Suneja G, Kayembe MK, Mmalane M, Rebbeck T, Rider JR, Essex M, Lockman S. Cancer Incidence following Expansion of HIV Treatment in Botswana. PLoS One. 2015; 10(8):e0135602.View Related Profiles.

Seage, George
Rider, Jennifer

PMID: 26267867; PMCID: PMC4534370; DOI: 10.1371/journal.pone.0135602;

Sinnott JA, Rider JR, Carlsson J, Gerke T, Tyekucheva S, Penney KL, Sesso HD, Loda M, Fall K, Stampfer MJ, Mucci LA, Pawitan Y, Andersson SO, Andrén O. Molecular differences in transition zone and peripheral zone prostate tumors. Carcinogenesis. 2015 Jun; 36(6):632-8. PMID: 25870172; PMCID: PMC4572920; DOI: 10.1093/carcin/bgv051;

Rider JR, Fiorentino M, Kelly R, Gerke T, Jordahl K, Sinnott JA, Giovannucci EL, Loda M, Mucci LA, Finn S. Tumor expression of adiponectin receptor 2 and lethal prostate cancer. Carcinogenesis. 2015 Jun; 36(6):639-47. PMID: 25863129; PMCID: PMC4481603; DOI: 10.1093/carcin/bgv048;

Graff RE, Pettersson A, Lis RT, DuPre N, Jordahl KM, Nuttall E, Rider JR, Fiorentino M, Sesso HD, Kenfield SA, Loda M, Giovannucci EL, Rosner B, Nguyen PL, Sweeney CJ, Mucci LA. The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer. Prostate. 2015 Jun 15; 75(9):897-906. PMID: 25728532; PMCID: PMC4424159; DOI: 10.1002/pros.22973;

Markt SC, Valdimarsdottir UA, Shui IM, Sigurdardottir LG, Rider JR, Tamimi RM, Batista JL, Haneuse S, Flynn-Evans E, Lockley SW, Czeisler CA, Stampfer MJ, Launer L, Harris T, Smith AV, Gudnason V, Lindstrom S, Kraft P, Mucci LA. Circadian clock genes and risk of fatal prostate cancer. Cancer Causes Control. 2015 Jan; 26(1):25-33. PMID: 25388799; PMCID: PMC4282953; DOI: 10.1007/s10552-014-0478-z;

Siddiqui MM, Wilson KM, Epstein MM, Rider JR, Martin NE, Stampfer MJ, Giovannucci EL, Mucci LA. Vasectomy and risk of aggressive prostate cancer: a 24-year follow-up study. J Clin Oncol. 2014 Sep 20; 32(27):3033-8. PMID: 25002716; PMCID: PMC4162499; DOI: 10.1200/JCO.2013.54.8446;

Sigurdardottir LG, Markt SC, Rider JR, Haneuse S, Fall K, Schernhammer ES, Tamimi RM, Flynn-Evans E, Batista JL, Launer L, Harris T, Aspelund T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA. Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men. Eur Urol. 2015 Feb; 67(2):191-4. PMID: 25107635; PMCID: PMC4318783; DOI: 10.1016/j.eururo.2014.07.008;

Markt SC, Rider JR, Penney KL, Schumacher FR, Epstein MM, Fall K, Sesso HD, Stampfer MJ, Mucci LA. Genetic variation across C-reactive protein and risk of prostate cancer. Prostate. 2014 Jul; 74(10):1034-42. PMID: 24844401; PMCID: PMC4063346; DOI: 10.1002/pros.22820;

Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, Judson GL, Lis R, Bailey D, Fiore C, Nuttall E, Martin NE, Stack E, Penney KL, Rider JR, Sinnott J, Sweeney C, Sesso HD, Fall K, Giovannucci E, Kantoff P, Stampfer M, Loda M, Mucci LA. SPINK1 protein expression and prostate cancer progression. Clin Cancer Res. 2014 Sep 15; 20(18):4904-11. PMID: 24687926; PMCID: PMC4167171; DOI: 10.1158/1078-0432.CCR-13-1341;

Sharma J, Gray KP, Harshman LC, Evan C, Nakabayashi M, Fichorova R, Rider J, Mucci L, Kantoff PW, Sweeney CJ. Elevated IL-8, TNF-a, and MCP-1 in men with metastatic prostate cancer starting androgen-deprivation therapy (ADT) are associated with shorter time to castration-resistance and overall survival. Prostate. 2014 Jun; 74(8):820-8. PMID: 24668612; DOI: 10.1002/pros.22788;

Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, Nordling S, Häggman M, Andersson SO, Spångberg A, Andrén O, Palmgren J, Steineck G, Adami HO, Johansson JE. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014 Mar 6; 370(10):932-42. PMID: 24597866; PMCID: PMC4118145; DOI: 10.1056/NEJMoa1311593;

Pettersson A, Lis RT, Meisner A, Flavin R, Stack EC, Fiorentino M, Finn S, Graff RE, Penney KL, Rider JR, Nuttall EJ, Martin NE, Sesso HD, Pollak M, Stampfer MJ, Kantoff PW, Giovannucci EL, Loda M, Mucci LA. Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG. J Natl Cancer Inst. 2013 Dec 18; 105(24):1881-90. PMID: 24292212; PMCID: PMC3866157; DOI: 10.1093/jnci/djt332;

Sharma J, Gray KP, Evan C, Nakabayashi M, Fichorova R, Rider J, Mucci L, Kantoff PW, Sweeney CJ. Elevated insulin-like growth factor binding protein-1 (IGFBP-1) in men with metastatic prostate cancer starting androgen deprivation therapy (ADT) is associated with shorter time to castration resistance and overall survival. Prostate. 2014 Feb; 74(3):225-34. PMID: 24132762; DOI: 10.1002/pros.22744;

Penney KL, Stampfer MJ, Jahn JL, Sinnott JA, Flavin R, Rider JR, Finn S, Giovannucci E, Sesso HD, Loda M, Mucci LA, Fiorentino M. Gleason grade progression is uncommon. Cancer Res. 2013 Aug 15; 73(16):5163-8. PMID: 23946472; PMCID: PMC3775342; DOI: 10.1158/0008-5472.CAN-13-0427;

Sigurdardottir LG, Valdimarsdottir UA, Mucci LA, Fall K, Rider JR, Schernhammer E, Czeisler CA, Launer L, Harris T, Stampfer MJ, Gudnason V, Lockley SW. Sleep disruption among older men and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):872-9. PMID: 23652374; PMCID: PMC3652595; DOI: 10.1158/1055-9965.EPI-12-1227-T;

Bill-Axelson A, Garmo H, Holmberg L, Johansson JE, Adami HO, Steineck G, Johansson E, Rider JR. Long-term distress after radical prostatectomy versus watchful waiting in prostate cancer: a longitudinal study from the Scandinavian Prostate Cancer Group-4 randomized clinical trial. Eur Urol. 2013 Dec; 64(6):920-8. PMID: 23465517; DOI: 10.1016/j.eururo.2013.02.025;

Schoenfeld JD, Margalit DN, Kasperzyk JL, Shui IM, Rider JR, Epstein MM, Meisner A, Kenfield SA, Martin NE, Nguyen PL, Kantoff PW, Giovannucci EL, Stampfer MJ, Mucci LA. A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer. Clin Cancer Res. 2013 Mar 15; 19(6):1612-9. PMID: 23382116; PMCID: PMC3602407; DOI: 10.1158/1078-0432.CCR-12-2718;

Chen YC, Huang YL, Platz EA, Alderete JF, Zheng L, Rider JR, Kraft P, Giovannucci E, Sutcliffe S. Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer. Cancer Causes Control. 2013 Jan; 24(1):175-80. PMID: 23179660; PMCID: PMC3549464; DOI: 10.1007/s10552-012-0103-y;

Popiolek M, Rider JR, Andrén O, Andersson SO, Holmberg L, Adami HO, Johansson JE. Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol. 2013 Mar; 63(3):428-35. PMID: 23084329; DOI: 10.1016/j.eururo.2012.10.002;

Davidsson S, Ohlson AL, Andersson SO, Fall K, Meisner A, Fiorentino M, Andrén O, Rider JR. CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer. Mod Pathol. 2013 Mar; 26(3):448-55. PMID: 23041830; DOI: 10.1038/modpathol.2012.164;

Rider JR, Sandin F, Andrén O, Wiklund P, Hugosson J, Stattin P. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study. Eur Urol. 2013 Jan; 63(1):88-96. PMID: 22902040; DOI: 10.1016/j.eururo.2012.08.001;

Epstein MM, Edgren G, Rider JR, Mucci LA, Adami HO. Temporal trends in cause of death among Swedish and US men with prostate cancer. J Natl Cancer Inst. 2012 Sep 5; 104(17):1335-42. PMID: 22835388; PMCID: PMC3529593; DOI: 10.1093/jnci/djs299;

Pettersson A, Graff RE, Bauer SR, Pitt MJ, Lis RT, Stack EC, Martin NE, Kunz L, Penney KL, Ligon AH, Suppan C, Flavin R, Sesso HD, Rider JR, Sweeney C, Stampfer MJ, Fiorentino M, Kantoff PW, Sanda MG, Giovannucci EL, Ding EL, Loda M, Mucci LA. The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2012 Sep; 21(9):1497-509. PMID: 22736790; PMCID: PMC3671609; DOI: 10.1158/1055-9965.EPI-12-0042;

Epstein MM, Andrén O, Kasperzyk JL, Shui IM, Penney KL, Fall K, Rider JR, Stampfer MJ, Andersson SO, Giovannucci E, Mucci LA. Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue. Cancer Causes Control. 2012 Aug; 23(8):1359-66. PMID: 22710747; PMCID: PMC3589913; DOI: 10.1007/s10552-012-0016-9;

Sigurdardottir LG, Valdimarsdottir UA, Fall K, Rider JR, Lockley SW, Schernhammer E, Mucci LA. Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1002-11. PMID: 22564869; PMCID: PMC3392423; DOI: 10.1158/1055-9965.EPI-12-0116;

Dhillon PK, Penney KL, Schumacher F, Rider JR, Sesso HD, Pollak M, Fiorentino M, Finn S, Loda M, Rifai N, Mucci LA, Giovannucci E, Stampfer MJ, Ma J. Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2618-27. PMID: 21960694; PMCID: PMC3700351; DOI: 10.1158/1055-9965.EPI-11-0434;

Davidsson S, Fiorentino M, Andrén O, Fang F, Mucci LA, Varenhorst E, Fall K, Rider JR. Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2011 Oct; 20(10):2280-7. PMID: 21953116; PMCID: PMC3671592; DOI: 10.1158/1055-9965.EPI-11-0373;

Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM, Stampfer MJ, Giovannucci E, Mucci LA. Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst. 2011 Jun 8; 103(11):876-84. PMID: 21586702; PMCID: PMC3110172; DOI: 10.1093/jnci/djr151;

Shui IM, Stark JR, Penney KL, Schumacher FR, Epstein MM, Pitt MJ, Stampfer MJ, Tamimi RM, Lindstrom S, Sesso HD, Fall K, Ma J, Kraft P, Giovannucci E, Mucci LA. Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality. Prostate. 2012 Feb 1; 72(2):209-16. PMID: 21563195; PMCID: PMC3175021; DOI: 10.1002/pros.21423;

Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, Nordling S, Häggman M, Andersson SO, Bratell S, Spångberg A, Palmgren J, Steineck G, Adami HO, Johansson JE. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2011 May 5; 364(18):1708-17. PMID: 21542742; DOI: 10.1056/NEJMoa1011967;

Penney KL, Sinnott JA, Fall K, Pawitan Y, Hoshida Y, Kraft P, Stark JR, Fiorentino M, Perner S, Finn S, Calza S, Flavin R, Freedman ML, Setlur S, Sesso HD, Andersson SO, Martin N, Kantoff PW, Johansson JE, Adami HO, Rubin MA, Loda M, Golub TR, Andrén O, Stampfer MJ, Mucci LA. mRNA expression signature of Gleason grade predicts lethal prostate cancer. J Clin Oncol. 2011 Jun 10; 29(17):2391-6. PMID: 21537050; PMCID: PMC3107753; DOI: 10.1200/JCO.2010.32.6421;

Andersson SO, Andrén O, Lyth J, Stark JR, Henriksson M, Adami HO, Carlsson P, Johansson JE. Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4). Scand J Urol Nephrol. 2011 Apr; 45(3):177-83. PMID: 21265595; DOI: 10.3109/00365599.2010.545075;

Kirrander P, Kolaric A, Helenius G, Windahl T, Andrén O, Stark JR, Lillsunde-Larsson G, Elgh F, Karlsson M. Human papillomavirus prevalence, distribution and correlation to histopathological parameters in a large Swedish cohort of men with penile carcinoma. BJU Int. 2011 Aug; 108(3):355-9. PMID: 21044240; DOI: 10.1111/j.1464-410X.2010.09770.x;

Meyer MS, Penney KL, Stark JR, Schumacher FR, Sesso HD, Loda M, Fiorentino M, Finn S, Flavin RJ, Kurth T, Price AL, Giovannucci EL, Fall K, Stampfer MJ, Ma J, Mucci LA. Genetic variation in RNASEL associated with prostate cancer risk and progression. Carcinogenesis. 2010 Sep; 31(9):1597-603. PMID: 20576793; PMCID: PMC2930803; DOI: 10.1093/carcin/bgq132;

Fiorentino M, Judson G, Penney K, Flavin R, Stark J, Fiore C, Fall K, Martin N, Ma J, Sinnott J, Giovannucci E, Stampfer M, Sesso HD, Kantoff PW, Finn S, Loda M, Mucci L. Immunohistochemical expression of BRCA1 and lethal prostate cancer. Cancer Res. 2010 Apr 15; 70(8):3136-9. PMID: 20388772; PMCID: PMC3049266; DOI: 10.1158/0008-5472.CAN-09-4100;

Mucci LA, Stark JR, Pollak MN, Li H, Kurth T, Stampfer MJ, Ma J. Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev. 2010 Feb; 19(2):484-91. PMID: 20142246; PMCID: PMC2820127; DOI: 10.1158/1055-9965.EPI-09-0836;

Stark JR, Mucci L, Rothman KJ, Adami HO. Screening for prostate cancer remains controversial. BMJ. 2009; 339:b3601.View Related Profiles.

Rider, Jennifer
Rothman, Kenneth

PMID: 19778971; DOI: 10.1136/bmj.b3601;

Stark JR, Judson G, Alderete JF, Mundodi V, Kucknoor AS, Giovannucci EL, Platz EA, Sutcliffe S, Fall K, Kurth T, Ma J, Stampfer MJ, Mucci LA. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J Natl Cancer Inst. 2009 Oct 21; 101(20):1406-11. PMID: 19741211; PMCID: PMC2765259; DOI: 10.1093/jnci/djp306;

Mucci LA, Stark JR, Figg WD, Schumacher F, Li H, Abe M, Hennessy K, Stampfer MJ, Gaziano JM, Ma J, Kantoff PW. Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study. Int J Cancer. 2009 Sep 1; 125(5):1143-6.View Related Profiles.

Gaziano, J. Michael
Rider, Jennifer

PMID: 19431146; PMCID: PMC2838373; DOI: 10.1002/ijc.24423;

Stark JR, Wiklund F, Grönberg H, Schumacher F, Sinnott JA, Stampfer MJ, Mucci LA, Kraft P. Toll-like receptor signaling pathway variants and prostate cancer mortality. Cancer Epidemiol Biomarkers Prev. 2009 Jun; 18(6):1859-63. PMID: 19505919; PMCID: PMC2833418; DOI: 10.1158/1055-9965.EPI-08-0981;

Stark JR, Li H, Kraft P, Kurth T, Giovannucci EL, Stampfer MJ, Ma J, Mucci LA. Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality. Int J Cancer. 2009 Jun 1; 124(11):2683-9. PMID: 19189403; PMCID: PMC2667697; DOI: 10.1002/ijc.24241;

Stark JR, Perner S, Stampfer MJ, Sinnott JA, Finn S, Eisenstein AS, Ma J, Fiorentino M, Kurth T, Loda M, Giovannucci EL, Rubin MA, Mucci LA. Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol. 2009 Jul 20; 27(21):3459-64.View Related Profiles.

Eisenstein, Anna
Rider, Jennifer

PMID: 19433685; PMCID: PMC2717753; DOI: 10.1200/JCO.2008.20.4669;

Fall K, Stark JR, Mucci LA, Chan J, Stampfer MJ, Kurth T, Febbo PG, Kantoff P, Ma J. No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk. Prostate. 2008 Sep 15; 68(13):1416-20. PMID: 18615538; PMCID: PMC2958090; DOI: 10.1002/pros.20797;

Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark JR, Adami HO, Andersson SO, Andrén O, Eisenstein A, Holmberg L, Huang W, Kantoff PW, Kim R, Perner S, Stampfer MJ, Johansson JE, Rubin MA. Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort. Cancer Epidemiol Biomarkers Prev. 2008 Jul; 17(7):1682-8.View Related Profiles.

Eisenstein, Anna
Rider, Jennifer

PMID: 18583469; PMCID: PMC2536630; DOI: 10.1158/1055-9965.EPI-08-0044;

LaPelle N, Costanza ME, Luckmann R, Rosal MC, White MJ, Stark JR. Staging mammography nonadherent women: a qualitative study. J Cancer Educ. 2008; 23(2):114-21. PMID: 18569247; DOI: 10.1080/08858190802039094;

Mucci LA, Pawitan Y, Demichelis F, Fall K, Stark JR, Adami HO, Andersson SO, Andrén O, Eisenstein AS, Holmberg L, Huang W, Kantoff PW, Perner S, Stampfer MJ, Johansson JE, Rubin MA. Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. Cancer Epidemiol Biomarkers Prev. 2008 Jan; 17(1):249-51.View Related Profiles.

Eisenstein, Anna
Rider, Jennifer

PMID: 18199732; DOI: 10.1158/1055-9965.EPI-07-0722;

Costanza ME, Luckmann R, Stoddard AM, White MJ, Stark JR, Avrunin JS, Rosal MC, Clemow L. Using tailored telephone counseling to accelerate the adoption of colorectal cancer screening. Cancer Detect Prev. 2007; 31(3):191-8. PMID: 17646058; DOI: 10.1016/j.cdp.2007.04.008;

Stark JR, Bertone-Johnson ER, Costanza ME, Stoddard AM. Factors associated with colorectal cancer risk perception: the role of polyps and family history. Health Educ Res. 2006 Oct; 21(5):740-9. PMID: 16801376; DOI: 10.1093/her/cyl049;

Costanza ME, Luckmann R, Stoddard AM, Avrunin JS, White MJ, Stark JR, Clemow L, Rosal MC. Applying a stage model of behavior change to colon cancer screening. Prev Med. 2005 Sep-Oct; 41(3-4):707-19. PMID: 16171854; DOI: 10.1016/j.ypmed.2004.12.013;

White MJ, Stark JR, Luckmann R, Rosal MC, Clemow L, Costanza ME. Implementing a computer-assisted telephone interview (CATI) system to increase colorectal cancer screening: a process evaluation. Patient Educ Couns. 2006 Jun; 61(3):419-28. PMID: 15993558; DOI: 10.1016/j.pec.2005.05.008;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 1 publications over 1 distinct years, with a maximum of 1 publications in 2017

Bar chart showing 1 publications over 1 distinct years, with a maximum of 1 publications in 2017

Year	Publications
2017	1

Media Mentions
Tweets

Note: X.com has changed/limited the ability to embed tweets directly in external sites and we are investigating ways to restore that functionality in BU Profiles. In the meantime we are displaying a link to your x.com profile in the Websites section above.

Prostate cancer: Having sex multiple times a week could stop cancer from developing, study suggests

Yahoo! News 8/11/2023

I am interested in mentoring graduate students and clinicians with an interest in cancer disparities, cancer prevention, or prognostic/predictive biomarkers.

Available to Mentor as: (Review Mentor Role Definitions):

Project Mentor
Research / Scholarly Mentor

Contact for Mentoring:

Email (see 'Contact Info')

Media Mentions

Yahoo! News